Why the study?
Does catheter closure using the new Amplatzer membranous VSD occluder safely and effectively close perimembranous VSDs in pediatric and young adult patients?
Does catheter closure using the new Amplatzer membranous VSD occluder safely and effectively close perimembranous VSDs in pediatric and young adult patients?
Transcatheter occlusion of membranous VSDs using the new Amplatzer device appears safe and effective in an initial small cohort, achieving immediate closure in all patients.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for the new Amplatzer device in perimembranous VSDs; larger prospective trials needed before adoption.
Hijazi et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: